ATE505482T1 - Impfstoff gegen infektiöses lachsanämievirus - Google Patents

Impfstoff gegen infektiöses lachsanämievirus

Info

Publication number
ATE505482T1
ATE505482T1 AT02785223T AT02785223T ATE505482T1 AT E505482 T1 ATE505482 T1 AT E505482T1 AT 02785223 T AT02785223 T AT 02785223T AT 02785223 T AT02785223 T AT 02785223T AT E505482 T1 ATE505482 T1 AT E505482T1
Authority
AT
Austria
Prior art keywords
infectious salmon
vaccine against
against infectious
anemia virus
salmon anemia
Prior art date
Application number
AT02785223T
Other languages
English (en)
Inventor
Stephane Villoing
Erik Biering
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Application granted granted Critical
Publication of ATE505482T1 publication Critical patent/ATE505482T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02785223T 2001-10-19 2002-10-16 Impfstoff gegen infektiöses lachsanämievirus ATE505482T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203951 2001-10-19
PCT/EP2002/011552 WO2003035680A1 (en) 2001-10-19 2002-10-16 Infectious salmon anaemia virus vaccine

Publications (1)

Publication Number Publication Date
ATE505482T1 true ATE505482T1 (de) 2011-04-15

Family

ID=8181091

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02785223T ATE505482T1 (de) 2001-10-19 2002-10-16 Impfstoff gegen infektiöses lachsanämievirus

Country Status (7)

Country Link
US (1) US7279167B2 (de)
EP (1) EP1440086B1 (de)
AT (1) ATE505482T1 (de)
CA (1) CA2464338C (de)
DE (1) DE60239753D1 (de)
NO (1) NO335085B1 (de)
WO (1) WO2003035680A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7578796B2 (en) * 2004-10-22 2009-08-25 General Patent Llc Method of shockwave treating fish and shellfish
JP2010514412A (ja) 2006-12-22 2010-05-06 ソリューシオネス バイオテクノロジカス イノヴァシオン リミターダ Ｄｎａ魚ワクチン
US8697085B2 (en) * 2011-06-17 2014-04-15 University Of Tennessee Research Foundation Group A Streptococcus multivalent vaccine
EP2753686A4 (de) * 2011-09-09 2015-06-03 Advanced Bionutrition Corp Bivalenter ipnv-isav-impfstoff unter verwendung einer virusähnlichen partikelplattform und verwendungsverfahren dafür
CN106749647A (zh) * 2016-02-18 2017-05-31 北京市农林科学院 鲑鳟鱼ihnv单克隆抗体及检测试剂盒
NO344698B1 (en) * 2018-06-15 2020-03-09 Patogen As Novel fish virus
CN109136200B (zh) * 2018-09-20 2022-02-18 中国水产科学研究院黑龙江水产研究所 一种重组传染性造血器官坏死病毒及其构建方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60017229D1 (de) 1999-10-18 2005-02-10 Akzo Nobel Nv DNA kodierend für das Strukturalprotein-1 vom infektiösen Lachs Anämie Virus und ihre Verwendungen
WO2002079231A2 (en) 2001-03-30 2002-10-10 Microtek International (1998) Ltd. Nucleic acids encoding isav polypeptides

Also Published As

Publication number Publication date
CA2464338C (en) 2014-12-02
NO335085B1 (no) 2014-09-08
EP1440086B1 (de) 2011-04-13
NO20041564L (no) 2004-04-16
DE60239753D1 (de) 2011-05-26
US20040253580A1 (en) 2004-12-16
WO2003035680A1 (en) 2003-05-01
EP1440086A1 (de) 2004-07-28
US7279167B2 (en) 2007-10-09
CA2464338A1 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
CY1122505T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
ATE461710T1 (de) Nipah-virus-impfstoffe
ATE528016T1 (de) Virusähnliche partikel als paramyxovirus- impfstoffe
CY1114243T1 (el) Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων
DK1326633T3 (da) Sammensætning omfattende immunogene mikropartikler
DE60121136D1 (de) Proteasom-influenzavirus-impfstoffzusammensetzung
CY1120430T1 (el) Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων
EA200700849A1 (ru) Первичная/бустерная противомалярийная вакцина
ATE426412T1 (de) Adjuvante influenza-vakzine
PL1951300T3 (pl) Zmiana równowagi TH1/TH2 w szczepionkach typu split przeciwko grypie zawierających adjuwant
CY1113540T1 (el) Εμβολια γριππης σκυλων
ATE473238T1 (de) Tuberkulose vaccine mit verbesserter effizienz
ATE517184T1 (de) Hcv ns3/4a kodierende nukleinsäure
WO2005035558A3 (en) Piscirickettsia salmonis antigens and use thereof
ATE505482T1 (de) Impfstoff gegen infektiöses lachsanämievirus
ATE427119T1 (de) Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung
ATE515270T1 (de) Phep, eine aminosäurepermease von staphylococcus aureus
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
NO20060395L (no) Antigenholdig dyrevaksine
DK1227840T3 (da) Adjuverede, genetiske vacciner
DE69534280D1 (de) Orale impfstoffe gegen yersinia pestis infektionen
TH88608A (th) สารผสมทางเภสัชกรรมซึ่งสามารถชักนำให้เกิดการตอบสนองเชิงปกป้องของภูมิคุ้มกันต้านไวรัส Dengue ซึ่งมีโปรตีนห่อหุ้มไวรัส Dengue

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties